Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.

Luís Silva Monteiro Lorena Castro Mariano Saman Warnakulasuriya

Published in: Oral diseases (2022)

The results of this SRMA support the role of podoplanin immunohistochemical expression as a potential predictive biomarker to assess the risk of malignancy development in oral leukoplakia.

Keyphrases

poor prognosis

binding protein

long non coding rna

human health